MeSH tree: C19.053.800.604
Evidence continues to mount regarding the effectiveness of treating primary aldosteronism (PA), with a major international study confirming that early intervention is the best way to beat this hidden cause of hypertension.
Sep 8, 2026
0
3
A common but often overlooked cause of high blood pressure may be hiding in plain sight—and data from a pioneering wearable device could hold the key to its earlier diagnosis, according to new research.
Aug 26, 2026
0
14
A simple new method based on the results of two studies from Christofer Juhlin's research group can make it easier to identify the underlying cause of a common form of high blood pressure and help predict who will benefit ...
Aug 18, 2026
0
5
Primary aldosteronism (otherwise known as PA or Conn Syndrome) is the leading endocrine cause of hypertension (high blood pressure). It carries a higher risk of stroke, heart attack, atrial fibrillation and kidney failure ...
Aug 11, 2026
0
5
A study of a new AI model examining 30 years of routine electronic health records (EHR) data could improve screening for primary aldosteronism, a leading cause of high blood pressure that is often unrecognized but increases ...
Jun 13, 2026
0
7
A new first-in-human study has validated a PET radiotracer that can effectively image overactive adrenal glands, offering an alternative to the highly invasive procedure currently utilized to diagnose primary aldosteronism. ...
Jun 1, 2026
0
3
Cedars-Sinai investigators have identified distinct genetic variants associated with resistant hypertension, a type of high blood pressure that remains uncontrolled despite medication. Their findings, published in the journal ...
Apr 6, 2026
0
10
A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high, despite taking several existing medicines, according to the results of a Phase III clinical trial led by a ...
Aug 30, 2025
0
1501
An international team of researchers led by Professor Morris Brown FRS at Queen Mary University of London found that Baxdrostat, a drug belonging to a new class of aldosterone synthase inhibitors, led to an average fall in ...
Jul 14, 2025
0
85
Kyushu University researchers have uncovered a surprising layer of complexity in aldosterone-producing adenomas (APAs)—adrenal gland tumors that drive high blood pressure. Using cutting-edge analysis techniques, they discovered ...
Feb 24, 2025
0
21
